Evaluation of an Oral Contraceptive Containing 0.150 mg Desogestrel and 0.020 mg Ethinylestradiol in Women Aged 30 Years or Older

Abstract

The oral contraceptive combination 0.150 mg desogestrel + 0.020 mg ethinylestradiol (Mercilon®) was investigated in an open multicenter study with the objective of evaluating efficacy, cycle control and side effects in women aged 30 years or older. Sixty-one investigators participated and included 434 women treated in a total of 7669 cycles. No pregnancies occurred, thus showing the combination studied to be highly effective. Furthermore, a good cycle control and an excellent acceptability were demonstrated.